|
From: Susanna-A S. <sa...@eb...> - 2007-10-02 22:16:16
|
> letter goes out (from this working group)and to our metabolomics community to explain what was done so far Presentation to meetings ( e.g. next Metabolomics Society meeting) with dedicated slots for discussions and workgroups is also helpful to engage with others. Susanna Rima Kaddurah-Daouk wrote: > > Excellent ideas Don and congratulations on new job with BMS. Would it > also help if a letter goes out (from this working group)and to our > metabolomics community to explain what was done so far, point them to > publications, ask them for their input and participation for next > phase and solicit ideas as to what next phase should achieve? reaching > editors is key and working with regulatory agencies a must. best rima > > > > > Don Robertson <don...@bm...> > Sent by: don...@bm... > > 10/02/2007 01:47 PM > > > To > Oliver Fiehn <of...@uc...> > cc > "'Susanna'" <sa...@eb...>, > msi...@li..., > rim...@du..., "'Goodsaid, Federico'" > <Fed...@fd...> > Subject > Re: [Msi-workgroups-board] Availability October 08-12 for TC with MSI > chairs - please respond > > > > > > > > > > Oliver/All, > > I think an important next step will be to gain feedback from the > consumers of standards (not necessarily the users). I think users > (those generating data) have had and continue to have the opportunity > for feedback, but my impression is that such feedback has been minimal > so far (though as I've been out of touch for a few months - maybe I've > missed a groundswell of interest?). By consumers, I mean journal > editors and regulators who might incorporate our standards into their > requirements for submissions (either manuscripts or regulatory > submissions). Maybe this is happening already??? If not, our telecon > with Federico may be a good first step so we can see how consumer > friendly the standards are in their present form and where we need to > expand or clarify things. I think we should also think about > contacting editors and/or editorial boards of relevant journals to > solicit feedback. I'm not sure how best to do that , but I hope you > or some of your academic colleagues might have suggestions for a > mechanism to accomplish that. > > My thoughts for what they are worth... > > BTW - from 10 -12 USEDT next week works for me Tuesday through > Thursday with no problem. Monday is doable but not ideal and Friday > is not very good at all. > > Don > > > > Oliver Fiehn wrote: > Dear Susanna, dear all, > > Now that all MSI documents are available online at the Metabolomics > journal site > (http://www.springerlink.com/content/j85g85483103/?p=69c352ecf23641afa10a372c251b9cf7&pi=0 > <http://www.springerlink.com/content/j85g85483103/?p=69c352ecf23641afa10a372c251b9cf7&pi=0> > ), we should discuss how to move forward. The view may be different > for different groups, so I would like to see opinions expressed from > each group chair. We will set up a date and time for a telephone > conference, but by experience, it may happen that not every WG chair > can join the discussion. In this case I would like to get input by > email from those chairs who eventually will not be able to join the TC. > > As for dates/time of the TC, we have a 9-hour time difference between > the U.S. pacific coast and central Europe. So, the time seems to be > fixed somewhere around > 7-9 a.m. Pacific (10-12 a.m. US east coast, 15:00-17:00 UK time, > 16:00-18:00 central Europe time). > With respect to the dates, please > tell me your availability for these times next week, i.e. Monday > October 08 to Friday October 12. > > A one hour TC should be fine. Please respond to me, no need to respond > to all on the list in order to reduce email traffic. > > Best > Oliver > > > Oliver Fiehn, Assoc. Prof. MCB > - Metabolomics - > UC Davis Genome Center > GBSF Building room 1315 > 451 East Health Sciences Drive > Davis (CA) 95616-8816 > > email of...@uc... <mailto:of...@uc...> > URL http://fiehnlab.ucdavis.edu/ > tel +1-530-754-8258 > fax +1-530-754-9658 > > > ------------------------------------------------------------------------ > > From: Susanna [mailto:sa...@eb...] > Sent: Mittwoch, 26. September 2007 12:17 > To: msi...@li... > <mailto:msi...@li...>; > rim...@du... <mailto:rim...@du...>; > of...@uc... <mailto:of...@uc...> > Cc: Goodsaid, Federico > Subject: FDA's request for teleconference with MSI chairs > Importance: High > > Dear Rima, Oliver and WGs' chairs, > > In the light of our latest papers, Federico Goodsaid* (FDA's CDER and > here cc-e) suggests having a Webex meeting to discuss the MSI activities. > As you can see from our communication -copied below- I have suggested > inviting the working groups' chairs (or alternative leading people), a > total of 5 people. > > I reckon this is a great opportunity, what do you think? > > If your positive, Federico will provide a Webex link from their/FDA > end. To start identifying possible date and time I have set up a > doodle page: > Go to http://www.doodle.ch/xsv4ur7h43bxvune and enter your > availability (Federico, please, you too). > Please, let me know if you cannot make any of the proposed dates > (approx last 2 weeks of October and early Nov). > > Best regards, > Susanna > > * Federico is also responsible for the "Guidance for Industry - > Pharmacogenomic Data Submissions" just released by FDA: > http://www.fda.gov/CBER/gdlns/pharmdtasubcomp.pdf > > > > -------- Original Message -------- > > Subject: > RE: Metabolomics standards' papers- Nature Biotechnology and > Metabolomics journal > Date: > Wed, 26 Sep 2007 13:08:31 -0400 > From: > "Goodsaid, Federico" <Fed...@fd...> > <mailto:Fed...@fd...> > To: > "Susanna" <sa...@eb...> <mailto:sa...@eb...> > References: > > > > > Susanna, > > Go ahead. Let me know of possible dates and times to do this. > > Thanks, > > Federico > > Federico Goodsaid, Ph.D. > Genomics Group > Office of Clinical Pharmacology > Office of Translational Science > Center for Drug Evaluation and Research > U.S. Food and Drug Administration > 10903 New Hampshire Avenue, Building 21, Room 3663 > Silver Spring, MD 20903-0002 > phone: 301-796-1535 > email: <email:%A0> Fed...@fd... > <mailto:Fed...@fd...> > > > > > ------------------------------------------------------------------------ > > From: Susanna [mailto:sa...@eb...] > Sent: Wednesday, September 26, 2007 12:44 PM > To: Goodsaid, Federico > Subject: Re: Metabolomics standards' papers- Nature Biotechnology and > Metabolomics journal > > Hi Federico, > > I would be happy to help. > Actually, I should report this to the rest of the MSI Board. > > I lead the ontology working group and provide links with MGED and > proteomics standard groups. To provide you with a summary overview of > the MSI activities, my suggestion would be to invite the other working > groups' leaders or other key people (4-5 people max?) . > > If you wish I can write to the MSI Board and cc to you. Please, let me > know. > > Thanks, > Susanna > > > Goodsaid, Federico wrote: > Susanna, > > Would you be ale to give us a Webex presentation about these > standards? We could provide a Webex link from this end. > > Thanks, > > Federico > > > Federico Goodsaid, Ph.D. > > Genomics Group > > Office of Clinical Pharmacology > > Office of Translational Science > > Center for Drug Evaluation and Research > > U.S. Food and Drug Administration > > 10903 New Hampshire Avenue, Building 21, Room 3663 > > Silver Spring, MD 20903-0002 > > phone: 301-796-1535 > > email: <email:%A0> Fed...@fd... > <mailto:Fed...@fd...> > > > > > > > ------------------------------------------------------------------------ > > From: Susanna [mailto:sa...@eb...] > Sent: Wednesday, September 26, 2007 10:16 AM > To: Lord, Peter [PRDUS] > Cc: Hattan, David G; Jacobson-Kram, David; 'Dix. David (E-mail); > Goodsaid, Federico; Eshete, Feleke; Frueh, Felix; Frank Sistare; > Friedlieb Pfannkuch (E-mail); Gregory Akerman (E-mail); 'Haymes. > Kenneth (E-mail); Elayan, Ikram; Fuscoe, James; Jean-Charles. Gautier > (E-mail); Jennifer Fostel (E-mail); Jim Stevens (E-mail); Leighton, > John K; John. N. Haselden (E-mail); Jonathan. Tugwood (E-mail); Joseph > F. Sina (E-mail); KDaniels (E-mail); Laura Suter-Dick {PRBN~Basel} > (E-mail); Freed, Lois M; McCarroll. Nancy (E-mail); Michael Lawton > (E-mail); Orr, Michael; Mike Waters (E-mail); Nie, Alex [PRDUS]; Pine, > P Scott; Roger Ulrich (E-mail); Ronald Snyder (E-mail); Francke, > Sabine; Thurmond, Scott; Spanhaak, Steven [PRDBE]; Choudhuri, > Supratim; Syril Pettit; Papoian, Thomas; Tong, Weida; William Mattes > (E-mail); Ying Jiang (E-mail) > Subject: Metabolomics standards' papers- Nature Biotechnology and > Metabolomics journal > > Dear All, > > several open access papers from the Metabolomics Standards Initiative > (MSI) are now available. > We look forward to your comments and participation in the future > activities. > > Best regards, > Susanna > > ******** > > Correspondence in Nature Biotechnology > (http://www.nature.com/nbt/journal/v25/n8/full/nbt0807-846b.html) > > > Sansone SA, Fan T, Goodacre R, Griffin JL, Hardy NW, Kaddurah-Daouk R, > Kristal BS, Lindon J, Mendes P, Morrison N, Nikolau B, Robertson D, > Sumner LW, Taylor C, van der Werf M, van Ommen B, Fiehn O. (2007) The > Metabolomics Standards Initiative. Nat Biotechnol. 2007 Aug;25(8):846-8. > > > Special issue papers in Metabolomics Journal > (http://springerlink.metapress.com/content/j85g85483103/?p=c2b8952a7cdb44398c0c4f2f7291c0c6&pi=0 > <http://springerlink.metapress.com/content/j85g85483103/?p=c2b8952a7cdb44398c0c4f2f7291c0c6&pi=0>) > > > Fiehn, O., Robertson, D., Griffin, J., van der Werf, M., Nikolau, B., > Morrison, N., Sumner, L.W., Goodacre, R., Hardy, N.W., Taylor, C., > Fostel, J., Kristal, B. Kaddurah-Daouk, R., Mendes, P., van Ommen, B., > Lindon, J.C. & Sansone, S.-A. (2007) The metabolomics standards > initiative (MSI). Metabolomics 3, 175-178. > > Griffin, J.L., Nicholls, A.W., Daykin, C., Heald, S., Keun, H., > Schuppe-Koistinen, I., Griffiths, J.R., Cheng, L., Rocca-Serra, P., > Rubtsov, D.V. & Robertson, D. (2007) Standard reporting requirements > for biological samples in metabolomics experiments: mammalian/in vivo > experiments. Metabolomics 3, 179-188. > > van der Werf, M.J., Takors, R., Smedsgaard, J., Nielsen, J., Ferenci, > T., Portais. J.C., Wittmann, C., Hooks, M., Tomassini, A., Oldiges, > M., Fostel, J. & Sauer, U. (2007) Standard reporting requirements for > biological samples in metabolomics experiments: microbial and in vitro > biology experiments. Metabolomics 3, 189-194. > > Fiehn, O., Sumner, L.W., Rhee, S.Y., Ward, J., Dickerson, J., Lange, > B.M., Lane, G., Roessner, U., Last, R. & Nikolau1, B. (2007) Minimum > reporting standards for plant biology context information in > metabolomic studies. Metabolomics 3, 195-201. > > Morrison, N., Bearden, D., Bundy, J.G., Collette, T., Currie, F., > Davey, M.P., Haigh, N.S., Hancock, D., Jones, O.A.H., Rochfort, S., > Sansone, S.-A., ©tys, D., Teng, Q., Field, D. & Viant, M.R. (2007) > Standard reporting requirements for biological samples in metabolomics > experiments: environmental context. Metabolomics 3, 203-210. > > Sumner, L.W., Amberg, A., Barrett, D., Beger, R., Beale, M.H., Daykin, > C., Fan, T.W.-M., Fiehn, O., Goodacre, R., Griffin, J.L., Hardy, N., > Higashi, R., Kopka, J., Lindon, J.C., Lane, A.N., Marriott, P., > Nicholls, A.W., Reily, M.D. & Viant, M. (2007) Proposed minimum > reporting standards for chemical analysis. Metabolomics 3, 211-221. > > Rubtsov, D.V., Jenkins, H., Ludwig, C., Easton, J., Viant, M.R., > Günther, U., Griffin, J.L. & Hardy, N. (2007) Proposed reporting > requirements for the description of NMR-based metabolomics > experiments. Metabolomics 3, 223-229. > > Goodacre, R., Broadhurst, D., Smilde, A., Kristal, B.S., Baker, J.D., > Beger, R., Bessant, C., Connor, S., Capuani, G., Craig, A., Ebbels, > T., Kell, D.B., Manetti, C., Newton, J., Paternostro, G., Somorjai, > R., Sjöström, M., Trygg, J. & Wulfert, F. (2007) Proposed minimum > reporting standards for data analysis in metabolomics. Metabolomics 3, > 231-241. > > Hardy, N.W. & Taylor, C.F. (2007) A roadmap for the establishment of > standard data exchange structures for metabolomics. Metabolomics 3, > 243-248. > > Sansone, S.-A., Schober, D., Atherton, H.J., Fiehn, O., Jenkins, H., > Rocca-Serra, P., Rubtsov, D.V., Spasic, I., Soldatova, L., Taylor, C., > Tseng, A., Viant, M.R. & The Ontology Working Group Members (2007) > Metabolomics standards initiative - ontology working group - work in > progress. Metabolomics 3, 249-256. > > > -- > Susanna-Assunta Sansone, PhD > > Project - Coordinator > www.ebi.ac.uk/net-project <http://www.ebi.ac.uk/net-project> > > > > > > > -- > Susanna-Assunta Sansone, PhD > > NET Project - Coordinator > > www.ebi.ac.uk/net-project <http://www.ebi.ac.uk/net-project> > > The European Bioinformatics Institute email: > <email:%A0> sa...@eb... <mailto:sa...@eb...> > EMBL Outstation - Hinxton direct: +44 (0)1223 494 691 > Wellcome Trust Genome Campus fax: +44 (0)1223 494 468 > Cambridge CB10 1SD, UK room: A229 > > > > > > -- > Susanna-Assunta Sansone, PhD > > NET Project - Coordinator > > www.ebi.ac.uk/net-project <http://www.ebi.ac.uk/net-project> > > The European Bioinformatics Institute email: sa...@eb... > <mailto:sa...@eb...> > EMBL Outstation - Hinxton direct: +44 (0)1223 494 691 > Wellcome Trust Genome Campus fax: +44 (0)1223 494 468 > Cambridge CB10 1SD, UK room: A229 > > > > ------------------------------------------------------------------------ > > ------------------------------------------------------------------------- > This SF.net email is sponsored by: Microsoft > Defy all challenges. Microsoft(R) Visual Studio 2005. > http://clk.atdmt.com/MRT/go/vse0120000070mrt/direct/01/ > > ------------------------------------------------------------------------ > > _______________________________________________ > Msi-workgroups-board mailing list > Msi...@li... > <mailto:Msi...@li...> > https://lists.sourceforge.net/lists/listinfo/msi-workgroups-board > [attachment "don.robertson.vcf" deleted by Rima > Kaddurah-Daouk/Psych/mc/Duke] |